A new investigational drug originally developed for type 2 diabetes is being readied for human clinical trials in search of the world's first treatment to impede the progression of Parkinson's disease following publication of new research.
Diabetes drug slows experimental Parkinson's disease progression, human trials to begin next year
Science Daily - 7 Dec 2016 21:32
A new investigational drug originally developed for type 2 diabetes is being readied for human clinical trials in search of the world's first treatment to impede the progression of Parkinson's disease following publication of new research.
Share this Article
Recommended